The objective of our study was to present modelbased estimates and pro jections on current and future health and economic impacts of cerebral palsy in Canada over a 20year time horizon .
Highlights
• A cerebral palsy diagnosis is accom panied by a substantial economic and social burden. • The number of newly diagnosed cases of cerebral palsy will rise from approximately 1800 in 2011 to nearly 2200 in 2031. • The number of people living with cerebral palsy is expected to increase from more than 75 000 in 2011 to more than 94 000 in 2031. • Canadians with cerebral palsy will continue to experience reduced quality of life, increased disabilities and a rising need for supportive services including informal care.
Introduction
Cerebral palsy is the most common cause of motor disability in childhood. 13 It is a heterogeneous group of neurological dis orders with motor impairments as the core feature. Individuals with cerebral palsy frequently have comorbid condi tions that further affect their function. 4 The comorbidities associated with cere bral palsy contribute to individual and family challenges and the financial costs related to the medical, rehabilitation and educational needs specific to each child.
Cerebral palsy results from disturbances to the developing brain at any time during pregnancy through early childhood (2 years of age). Congenital cerebral palsy refers to prenatal and perinatal aetiologies before 28 days of life, while postnatal cerebral palsy refers to aetiologies from 28 days of life until 2 years of age. Cerebral palsy has multiple causes, clinical subtypes, associ ated comorbidities and functional out comes. The diversity in terms of the onset, neuromotor impairment pattern, severity across functional domains, presence of multiple health conditions or diseases, secondary complications and available interventions makes it nearly impossible to categorize cerebral palsy according to a single classification. 5 Not surprisingly, multiple risk factors are associated with the condition during the prenatal (prior to labour and delivery), perinatal (during the birthing process) and postnatal (after birth in the first 2 years of life) periods. 39 Risk factors include premature birth, intrauterine growth restriction, intrauterine infection/inflam mation, male sex, consanguinity, stroke prior to 2 years of age and hypoxic isch emic encephalopathy. Nevertheless, the specific causal mechanism remains elu sive for most children with cerebral palsy. Most children are diagnosed in the first 2 years of life, 10 although some diagnoses may not occur until later in childhood. 11, 12 Very little has changed over the past decade in the global prevalence of cere bral palsy. 16, 8, 1318 A recent metaanalysis reported the birth prevalence of cerebral palsy in developed countries to be 2.11 per 1000 live births. 3 However, population based studies have reported prevalence estimates ranging from 1.5 to approxi mately 4 per 1000 live births, and highest in countries with higher incidence of con sanguinity. 1923 The lack of casevalidated algorithms for identifying cerebral palsy 24 in administrative health databases may contribute to variability in estimated prev alence as diagnostic code misclassification may be occurring.
The variability in cerebral palsy prevalence estimates across the world and within Canada may also be due to differences in the criteria used for diagnosing the condi tion, 24, 25 as well as differences in pre and perinatal care in some populations. Studies conducted in Alberta 26 , British Columbia 27 and Quebec 28 have reported prevalence estimates similar to the worldwide esti mates. Using administrative databases, Alberta reported an estimate of 2.57 per 1000 live births at 8 years, 26 while the fig ure in British Columbia was 2.68 per 1000 live births. 27 Using data from a Quebec cerebral palsy registry, Oskoui et al. 13 reported an estimate of 2.30 per 1000 chil dren. A more recent Quebec study deter mined the prevalence of cerebral palsy to be 1.8 per 1000 children (95% confidence interval [CI]: 1.6-2.1), based on data from a cerebral palsy registry versus 2.0 per 1000 children (95% CI: 1.9-2.3) based on data from administrative health databases. 28 Although these estimates are comparable, the concordance in diagnosis between the two databases showed a kappa of 0.62 (95% CI: 0.57-0.67), where a selection bias was seen in the administrative health databases cases. 28 In effect, children with confirmed cerebral palsy who were born preterm were more likely than those born at term to be captured by administrative databases because preterm children tend to receive more specialized developmental care that often leads to correct diagnosis and coding of their condition.
A diagnosis of cerebral palsy comes with a substantial economic and social burden to individuals, families and society in gen eral. The burden can be exacerbated when relevant information for the development of effective health policies, strategies and programs is limited or unavailable. 29 The NPHSNC set the goal of examining future incidence, prevalence and impact of neurological conditions examined over 5, 10, 15 and 20year horizons. This manuscript focuses on the longest horizon, 20 years, for the model projections.
The objective of our study was to present modelbased estimates and projections on current and future health and economic impacts of cerebral palsy in Canada over a 20year time horizon (2011-2031).
Methods

POHEM-Neurological
The POHEM-Neurological framework is an empirically grounded model that uses Canadian data for demographics and dis ease incidence and mortality to produce projections over the life cycle of Canadians. 3034 The model's basic unit of analysis is the individual, or "actor," whose life course is simulated and mod elled in continuous time using a Monte Carlo approach.*
The dynamic simulation recreates a syn thetic Canadian population at a given point in time (historically and in the future) and ages it, one actor at a time, until each actor's death. Lastly, the model uses status quo assumptions to project future impacts; as such, it assumes that incidence and risk and prognostic factors for the neurological condition being mod elled will remain stable throughout the projection period. Further details regard ing the methods and procedures involved in POHEM-Neurological can be found elsewhere. 3034 The model development process for POHEM-Neurological can be broken into four steps: (1) initialization; (2) yearly updates; (3) model validation; and (4) pro jection (see Table 1 ). We used only Canadian, populationbased data sources for model initialization and yearly updates.
Step 1: Initialization
Initialization began with historic birth cohorts from 1872 through 2006, which we subjected to the observed historic death rate, as with other Statistics Canada health models. 35, 36 Since 1872 represents Step 2: Yearly updates of actors' health profiles An actor's health profile consists of six characteristics: (1) demographics; (2) cere bral palsy status; (3) health status; (4) pres ence of an informal caregiver; (5) health care costs; and (6) mortality. Each actor's health profile is updated over time, either at an event (e.g. birthday, date of diagno sis of cerebral palsy) or at the change of the calendar year, depending on the pro file characteristic. All characteristics were calculated and modelled for people with cerebral palsy and those without neuro logical conditions. "People with no neuro logical conditions," as opposed to those without cerebral palsy, was the compari son used because people with cerebral palsy tend to have other comorbid costs that are difficult to separate out (see "Comorbidity, counterfactual population and costs estimation").
Cerebral palsy status: incidence, prevalence and mortality
We applied sex and agespecific cerebral palsy incidence rates to the model's synthetic Canadian population at the beginning of each calendar year. We estimated inci dence rates of cerebral palsy using a case identification algorithm that used British Columbia health administrative data from physician billings and hospital discharge abstracts. A case of cerebral palsy was defined as one physician visit or one hospitalization that used the following International Classification of Disease (ICD) codes for cerebral palsy: (1) ICD10 code G80 (2) ICD9 code 340; or (3) ICD9(CM) codes 333.71 or 343. We developed the algorithm with advice from the Canadian Chronic Disease Surveillance System (CCDSS) Neurological Conditions Working Group chaired by the Public Health Agency of Canada.
Based on additional advice from clinical experts in the CCDSS Working Group, we defined incident cases of cerebral palsy as only occurring prior to age 20 years since most children receive a diagnosis in early childhood; after 20 years of age, incidence was assumed to be zero. Incident cerebral palsy cases accumulate over time to gen erate prevalent cases of cerebral palsy. Relative mortality risks specific to cerebral palsy were applied to actors with cerebral palsy. We estimated sex and agespecific mortality rates using the same case defini tion and data used to estimate incidence. The mortality rates specific to cerebral palsy were divided by the mortality rates for the same sex and age group in the gen eral population, thereby generating a rela tive mortality risk. In POHEM-Neurological, this relative mortality risk for people with cerebral palsy was multiplied by the base line mortality rate for the Canadian popula tion. In essence, mortality rates for the cerebral palsy population in British Columbia were compared to the mortality rates of the general population (obtained from Statistics Canada), the latter being a combination of life tables and demographic projections. 36 For future projections, the general population's mortality rate is antic ipated to gradually decrease over time, reflecting the projected mortality using birth cohorts and the Lee-Carter model as estimated by Statistics Canada. 37 This means that the projected mortality of Canadians with cerebral palsy decreased at the same rate as for those without cerebral palsy. This is an assumption of the POHEM-Neurological model as it incorpo rates a parameter that allows for an increase or decrease in the relative mortal ity risk for people with cerebral palsy com pared to those without.
During model validation, the modelpro jected prevalence of cerebral palsy was much higher than that observed in the British Columbia administrative data (see Figure 1 ). After consulting with clinical experts on the modelprojected prevalence, an adjustment parameter was added to POHEM-Neurological that would remove a diagnosis of cerebral palsy from a † LifePaths is a dynamic longitudinal microsimulation model of Canadian individuals and families that simulates and generates basic individual and family decisions for most discrete events that together constitute an individual's life history. LifePaths creates synthetic life histories from birth to death that are representative of the history of Canada's population. Figure 1 ), the modelgenerated prevalence "rates" ‡ approached those reported in the literature. 3, 1923 Health status The Health Utilities Index Mark 3 (HUI3) is a generic preferencebased measure of healthrelated quality of life that is used to ascertain disease severity. 39 Healthrelated quality of life is a concept that describes the health of populations and represents a broader health outcome for population health analyses than mortality rates or life expectancy. HUI3 is a utilitybased measure that reflects health states with a variety of severity levels, ranging from perfect health proportion of individuals who had previ ously been prevalent cerebral palsy cases in the model. Although cerebral palsy is a lifelong disorder, the observed incidence rates likely included a high proportion of falsepositive diagnoses in the administra tive health data source, such as children who were initially given a cerebral palsy code but who were later given a different diagnosis. Although, the standard error and statistical error of the case definition were not validated for this study, the case definition of a single diagnostic code for cerebral palsy within administrative data bases has been validated in the Quebec population and found to be highly specific but with lower sensitivity. Aligned with this, the prediction model had a much higher prevalence of cerebral palsy pre dicted, and it was modified to adjust for this difference in sensitivity. Since the validity of diagnostic codes for cerebral palsy in administrative databases has not yet been established, 28 our study method ology can be considered as the best cur rently available for predicting cerebral palsy in administrative databases in Canada, being as it is highly specific and providing information that is of value. 28 Evidence of misdiagnoses of neurogenetic disorders as cerebral palsy in early life has been recognized. 38 After adjustment (see ‡ Since POHEM's basic unit of analysis is the individual person, it creates a population and ages it, one person at a time, until death. The prevalence estimates from POHEM-Neurological can be considered to be rates because the model calculations took into account the person-years of time contributed by an individual over the calendar year and in the disease state in both the numerator and denominator during the modeling process. (HUI3 = 1.0) through death (HUI3 = 0). It includes states considered to be worse than death (minimum HUI3 = −0.36). 39 The HUI3 assesses functional health across eight dimensions-cognition, emotion, mobility, dexterity, pain and discomfort, speech, vision and hearing-and provides a valid measure of the functional health status and quality of life experienced by people with cerebral palsy. 39, 40 Disability categories have been previously validated for HUI3: none (1.00); mild (0.89 to 0.99); moderate (0.70 to 0.88); and severe (less than 0.70). 41 It should be noted that HUI3 scores can vary depending on the source of valuation, which could either be by proxy or child. A 2019 study 42 reported that HUI3 values can range from −0.013 to +0.84 for children with cerebral palsy. For individuals aged 15 years and older with cerebral palsy, mean HUI3 values (with standard errors) were estimated from the 2011 Survey on Living with Neurological Conditions in Canada (SLNCC). 43 Means were calculated separately for males and females, and for two age groups: 15-34 years and 35 years and older. For chil dren younger than 15 years with a diagnosis of cerebral palsy, a population not covered by the SLNCC, mean HUI3 values were estimated from the 2006 Participation and Activity Limitations Survey (PALS). 44 The estimate was derived for boys and girls combined (i.e. it was not sex specific).
The impact of cerebral palsy can also be assessed by the years of life lost due to the condition, that is, years lost due to prema ture death from a disease. To calculate years of life lost, we first determined the age of death for all actors with cerebral palsy in each calendar year. Next, we esti mated years of life lost for a scenario in which the mortality hazard for cerebral palsy was the same as for actors without cerebral palsy and recalculated the age of death: years of life lost was the difference in age of death between the two calcula tions. Healthadjusted life years lost indi cates the years of life lost living in a healthy state, combining morbidity and mortality. Healthadjusted life years (HALYs) were estimated from the product of years of life lived (age at death) multiplied by the annual HUI3 for each actor over their lifetime.
The presence of an informal caregiver Informal caregiving refers to unpaid care provided by family and friends to Canadians living with a chronic health condition, dis ability or aging needs.
For each actor in POHEM-Neurological, we assessed the likelihood of having an informal caregiver based on the actor's age, cerebral palsy status and health sta tus (HUI3). If an individual was assigned the presence of an informal caregiver, additional characteristics were assigned based on empirical estimates from the 2011 SLNCC and augmented with the 2012 General Social Survey (GSS) 45 : (1) hours of care received; (2) health status of their caregiver; and (3) outofpocket expenses incurred by caregivers.
Health care costs
We estimated formal health care costs in incident and prevalent cohorts with cere bral palsy and ascertained these costs using administrative health data in British Columbia and Ontario. The health care costs were estimated using 2010dollar values; as such, inflation was not factored into the cost projections. In addition, prevalent and counterfactual cohort costs were obtained for the period 1 April 2009 through 31 March 2010, in both Ontario and British Columbia.
We examined incident cohort costs in Ontario over the same period. We obtained available incident cohort costs in British Columbia for the 12month period starting on 1 April of the incident year (2006, 2007 or 2008) . Formal health care costs were those covered by provincial health plans in health components grouped as follows: (1) acute hospitalization; (2) physician ser vices; (3) prescription drug data; § (4) reha bilitation hospitals; (5) Ontario provincially funded home care; (6) Ontario residence and care in a longterm care facility; and (7) Ontario provincially funded assistive devices. Costs included two categories of outofpocket costs (expenses paid by an individual but not refunded by insurance or government): those of the patient and those for the caregiver.
Comorbidity, counterfactual population and costs estimation
As noted previously, individuals with cerebral palsy frequently have comorbid conditions. For instance, one in four chil dren with cerebral palsy have epilepsy, one in two have an intellectual disability, and one in four have a behaviour disorder, including Autism Spectrum Disorder, and other musculoskeletal conditions. 4, 47 As such, it is sometimes difficult to isolate the contribution of cerebral palsy to health care costs, caregiving or mortality from those due to comorbidities. To address this issue, we identified a counterfactual (nonneurological condition) population cohort to determine the net impact of cerebral palsy. For example, if the preva lence of comorbidity X is greater in indi viduals with cerebral palsy than those without, the additional health care costs (or receipt of caregiving hours) associated with this greater morbidity should be attributed to individuals with cerebral palsy. Thus, costs over and above those of the agesex counterparts without a neuro logical condition were attributed as being the additional direct cost burden of the neurological condition irrespective of comorbid conditions. Conversely, if indi viduals with cerebral palsy use less of a particular health care resource than those without a neurological condition, our model should also reflect this lower utilization.
The counterfactual nonneurological con dition cohort consisted of all individuals in the respective datasets who had not otherwise been classified as having any of the seven neurological conditions of inter est for the NPHSNC microsimulation proj ect, namely Alzheimer disease and other dementias, multiple sclerosis, cerebral palsy, epilepsy, Parkinson disease and parkin sonism, traumatic brain injuries and trau matic spinal cord injuries.
Step 3: POHEM-Neurological validation
The cerebral palsy prevalence "rates" were derived from an unvalidated case algo rithm that was used during feasibility studies as part of the NPHSNC (see Figure 1 ). As such adjustments were made to calibrate the POHEM-Neurological cere bral palsy prevalence projections to align with the widely accepted prevalence bench mark of 2.5 per 1000 live births cited in systematic reviews and literature. 3, 1923 (See "
Step 2: Yearly updates of actors' health profiles".) § British Columbia had comprehensive prescription drug cost data for all prescriptions dispensed in community pharmacies, regardless of age, while Ontario had comprehensive data for persons aged 65 years and older with limited data for lower-income cerebral palsy patients receiving provincial support for their disease-modifying therapies. Where we had costs from both provinces, these were weighted based on an input parameter (75% Ontario, 25% British Columbia). The method used for this analysis was based on Wodchis et al. 46 Step 4: Projection
We projected multiple main model out puts through to 2031 including incident and prevalent cerebral palsy cases in Canada; years of life lived with cerebral palsy; HALY; health care costs including costs for each of the seven sectors; outof pocket expenses; and hours of informal caregiving. In addition, we projected three parameters from the perspective of caregivers: hours of caregiving; outof pocket expenses; and health status (HUI3).
Results
According to POHEM-Neurological pro jections, the number of children under 20 years of age who will be newly diag nosed with cerebral palsy will increase from approximately 1800 in 2011 to nearly 2200 in 2031 ( Figure 2 ). The rate of cere bral palsy incidence remains stable over the projection period, around 0.3 per 1000 for children less than 20 years old. The majority of the incident cases will occur among children between 1 and 5 years of age, as most cases of cerebral palsy are diagnosed in the first 2 years of a child's life (data not shown).
As with incidence, the number of people with cerebral palsy is expected to increase from more than 75 000 in 2011 to more than 94 000 in 2031, although the preva lence only shows a slight increase over this period, from 2.2 in 2011 to 2.4 per 1000 population in 2031 ( Figure 3) . The increase can be attributed to the growth of the Canadian population and the increased life expectancy.
In 2011, Canadians with cerebral palsy had reduced functional health (as defined by HUI3 scores) compared with Canadians without neurological conditions. Average HUI3 for Canadians with cerebral palsy was below 0.7, the cut point for "severe disability," at all ages (Figure 4 ). The aver age HUI3 for Canadians without a neuro logical condition was between 1.0 and 0.8; only upon reaching 80 years of age does the average HUI3 score fall below 0.7. The difference in the HUI3 trend remained relatively stable because the model assumes no change in agespecific HUI3 scores.
Given the lower functional health of Canadians with cerebral palsy, the increased demand for informal care is not surpris ing. A much larger proportion of individuals with cerebral palsy than those without a neurological condition receive informal caregiving; this holds true at all ages ( Figure 5 ). Overall, individuals with cere bral palsy start to receive informal care at an earlier age, and the proportion receiv ing informal care rises sharply, remaining consistently higher than among their coun terparts without a neurological condition.
People without a neurological condition only begin to require greater amounts of informal care as they approach 70 years of age.
POHEM-Neurological also projects that individuals aged over 35 years will receive considerably more hours of informal care per week than Canadians who do not have cerebral palsy, that is, 30 versus 18 hours per week ( Figure 6 ).
We measured years of life lived with a condition and HALYs to assess the impact of cerebral palsy on the quality of life of Canadians. Figure 7 shows years of life lived and HALYs for Canadians with cere bral palsy and their counterparts without a neurological condition, by decade of birth. The model projects that people born between 2010 and 2020 will have longer periods in poor health than their peers without a neurological condition. Women with cerebral palsy are projected to lose, on average, about 41 years of life in good health, while men with cerebral palsy are expected to lose approximately 33 years. In comparison, Canadian women who do not have a neurological condition are expected to lose about 13 years of life in good health while their male counterparts are expected to lose about 11 years. Another important difference between Canadians with cerebral palsy and their counterparts who do not have the condi tion is that their health care expenditures tend to be higher. Table 2 compares mean per capita total health sector costs for Canadians with cerebral palsy and those who do not have a neurological condition.
The comparison shows that the greatest differences in costs occur prior to age 15 years. Around age 20 years, the cost differences begin to decrease (a ratio of 14:1) considerably and level off as people continue to age. By age 30 years, the ratio of total health care costs falls to 7:1. The model projects that the total mean per capita total health care costs will remain stable over the 20year projection period because no change in costs per year was assumed.
The impact of living with cerebral palsy was also assessed by comparing the out ofpocket expenses incurred by informal caregivers of Canadians with cerebral palsy and of those without a neurological condi tion. The difference was highest for infor mal caregivers of individuals aged under 35 years, with outofpocket expenses almost 50 times greater for caregivers of individu als with cerebral palsy than for those car ing for individuals without a neurological condition (see Figure 8 ). A 36fold differ ence is seen for informal caregivers of individuals aged 35-65 years. After age 65 years, the differences in outofpocket expenses are not as substantial.
As with other POHEM-Neurological param eters, the outofpocket expenses trend in 2011 is not expected to change by 2031 due to the status quo assumptions used during the modelling process. Figure 9 also shows that total health sec tor costs associated with living with cere bral palsy will rise consistently over the next 20 years while the cost of care not related to cerebral palsy will remain stable over the same period.
Discussion
POHEM-Neurological projects the epide miological and economic impacts of cere bral palsy over a 20year period. Although the age and sexspecific incidence of cerebral palsy was assumed to be constant over the projection period, the model projects an increase in the number of Canadians with cerebral palsy, from more than 75 000 in 2011 to more than 94 000 by 2031. As cerebral palsy is a chronic medi cal condition, more longterm supportive care services may be required to deal with the increase in the number of people with the condition.
In addition, POHEM-Neurological reflects the fact that people with cerebral palsy tend to have longer periods in poorer healthrelated quality of life (as reflected by lower scores on the HUI3) than their counterparts who do not have the condi tion. Although the core feature of cerebral palsy is nonprogressive motor impairment, cognitive impairment, feeding difficulties, approximately 33% compared to less than 1% for costs not related to cerebral palsy. In addition, people with cerebral palsy and their families are expected to incur substantial outofpocket costs. As medi cal care and treatments advance, an increasing number of children with cere bral palsy are reaching adulthood. How ever, the provision of health care services and specialized programs tends not to keep pace with the needs of families and indi viduals, thereby making the transition from childhood into adulthood a challenge. 14, 48, 49 As people with cerebral palsy experience a loss or reduction in the provision of health care services when they transition to adulthood, their demand for informal caregiving increases, and parents and rela tives often step in to provide financial support and the required care. As noted in our study, the hours provided of informal care per week and outofpocket expenses incurred by the caregivers of people with cerebral palsy are substantially higher than those incurred by the relatives or friends of those who do not have the con dition. The economic impact in terms of loss of income for informal caregivers is also an issue that requires more attention over the next 20 years as the impact of this condition is assessed.
Strengths and limitations
Our study offers important insights that strengthen our understanding of a com plex neurological condition. POHEM-Neurological projections can help in the planning of future health programs and strategies for Canadians living with cere bral palsy.
The present findings from POHEM-Neurological assumed no future change in age and sexspecific cerebral palsy inci dence, relative mortality or functional health (HUI3). As such, the primary driv ers of future prevalence, impact and cost of cerebral palsy derived from POHEM-Neurological are based on projected demographic shifts of the Canadian popu lation. However, future iterations of the model could evaluate alternate scenarios, such as cost discounting, or variations in incidence or relative mortality, for their impact on the future of cerebral palsy in Canada.
Although incidence, mortality and costs were derived from Canadian provincial administrative data, the case definition Year seizure activity, vision and mobility impair ment are commonly associated conditions that may progress over time. Our study found that women living with cerebral palsy lose, on average, about 41 years of life in good health compared with Canadian women who do not have the condition: this value was about 33 years for men. The difference in HALYs between men and women is largely due to differences in life expectancy as women live longer in poorer health (see Figure 7 ).
Long periods living in poor health and functional disability can result in an increased burden on the affected individ uals and their families as well as on the health care system.
Total health care costs in all categories for Canadians with cerebral palsy will rise by algorithm for identifying individuals with cerebral palsy had not been validated at the time of implementation. In initial assessments, modelprojected prevalence rates were notably higher than observed rates. Therefore, a parameter was included in POHEM-Neurological that would, for a subset of actors, remove the designation of cerebral palsy from some prevalent cases. Such a parameter accounts for potential misdiagnosis, which is known to occur-hence the term "masqueraders of cerebral palsy." 38 A recent Canadian study compared an administrative databased definition of cerebral palsy to a registry based approach and found that 41% of cases administratively identified were not in the registry and that the former also missed 34% of registrycaptured cases. 28 Therefore, a more sensitive definition of cerebral palsy may be needed if adminis trative data are to be used to capture inci dence and costs associated with this condition. Alternatively, a combination of methods that included combining ICD codes and cerebral palsy diagnoses writ ten in medical or educational records, as described in a 2019 study, 50 can be further analyzed to reduce errors in identifying cerebral palsy cases.
Limitations of POHEM-Neurological micro simulation models are expansively dis cussed in studies by Finès et al., 30 Manuel et al., 31 Amankwah et al. 32 and Hennessy et al. 51 Limitations such as applying inci dence and mortality data obtained from one province to the entire nation, health care costs from two provinces, type I and II model error uncertainties and adjust ments made to reduce the effects of the limitations are addressed in these studies.
Conclusion
Our study findings suggest that Canadians with cerebral palsy will continue to expe rience reduced quality of life, increased disabilities and a rising need for support ive services, including informal care. Health care expenditures, particularly out ofpocket expenses, are projected to remain high over the next 20year period. As people with cerebral palsy tend to have a normal life expectancy, they face con tinuous challenges related to an ongoing need for specialized medical care, accom modated education services, developmen tal assistance and general assisted living support. In addition, the indirect costs of lost productivity and wages to individuals and society, as well as occupational limitations, needs to addressed. More attention may be required for the transi tional needs of people living with cerebral palsy as they pass through the different stages of life in situations where appropri ate health care services and programs are inadequate or lacking.
